Oramed Pharmaceuticals (Israel) Market Value
| ORMP Stock | 8.60 0.02 0.23% |
| Symbol | Oramed |
Oramed Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oramed Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oramed Pharmaceuticals.
| 03/25/2024 |
| 04/24/2024 |
If you would invest 0.00 in Oramed Pharmaceuticals on March 25, 2024 and sell it all today you would earn a total of 0.00 from holding Oramed Pharmaceuticals or generate 0.0% return on investment in Oramed Pharmaceuticals over 30 days. Oramed Pharmaceuticals is related to or competes with Nice, Bank Leumi, ICL Israel, Mizrahi Tefahot, Azrieli, Elbit Systems, and Israel Discount. Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the use of orally in... More
Oramed Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oramed Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oramed Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 28.82 | |||
| Information Ratio | 0.2141 | |||
| Maximum Drawdown | 12044.83 | |||
| Value At Risk | (8.04) | |||
| Potential Upside | 12.82 |
Oramed Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oramed Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oramed Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Oramed Pharmaceuticals historical prices to predict the future Oramed Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.1419 | |||
| Jensen Alpha | 492.54 | |||
| Total Risk Alpha | 199.55 | |||
| Sortino Ratio | 17.35 | |||
| Treynor Ratio | 5.26 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Oramed Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Oramed Pharmaceuticals Backtested Returns
Oramed Pharmaceuticals is out of control given 3 months investment horizon. Oramed Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of 0.22, which implies the firm had a 0.22% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 54.97% are justified by taking the suggested risk. Use Oramed Pharmaceuticals Risk Adjusted Performance of 0.1419, downside deviation of 28.82, and Standard Deviation of 2335.14 to evaluate company specific risk that cannot be diversified away. Oramed Pharmaceuticals holds a performance score of 17 on a scale of zero to a hundred. The company holds a Beta of 95.0, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oramed Pharmaceuticals will likely underperform. Use Oramed Pharmaceuticals mean deviation, coefficient of variation, variance, as well as the relationship between the downside deviation and standard deviation , to analyze future returns on Oramed Pharmaceuticals.
Auto-correlation | -0.1 |
Very weak reverse predictability
Oramed Pharmaceuticals has very weak reverse predictability. Overlapping area represents the amount of predictability between Oramed Pharmaceuticals time series from 25th of March 2024 to 9th of April 2024 and 9th of April 2024 to 24th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oramed Pharmaceuticals price movement. The serial correlation of -0.1 indicates that less than 10.0% of current Oramed Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.1 | |
| Spearman Rank Test | -0.6 | |
| Residual Average | 0.0 | |
| Price Variance | 0.41 |
Oramed Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Oramed Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oramed Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Oramed Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Oramed Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oramed Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oramed Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oramed Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oramed Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Oramed Pharmaceuticals Lagged Returns
When evaluating Oramed Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oramed Pharmaceuticals stock have on its future price. Oramed Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oramed Pharmaceuticals autocorrelation shows the relationship between Oramed Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Oramed Pharmaceuticals.
Regressed Prices |
| Timeline |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Oramed Pharmaceuticals Correlation, Oramed Pharmaceuticals Volatility and Oramed Pharmaceuticals Alpha and Beta module to complement your research on Oramed Pharmaceuticals. For information on how to trade Oramed Stock refer to our How to Trade Oramed Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Oramed Stock analysis
When running Oramed Pharmaceuticals' price analysis, check to measure Oramed Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oramed Pharmaceuticals is operating at the current time. Most of Oramed Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Oramed Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oramed Pharmaceuticals' price. Additionally, you may evaluate how the addition of Oramed Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |
Oramed Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.